Related Experiment Video

Updated: May 9, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

SIPAR negatively regulates STAT3 signaling and inhibits progression of melanoma

Fangli Ren1, Fuqin Su, Hongxiu Ning

  • 1State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Medicine, School of Life Sciences, Tsinghua University, Beijing 100084, China.

Cellular Signalling
|August 7, 2013
PubMed

Insights

STAT3-Interacting Protein As a Repressor (SIPAR) inhibits melanoma progression by accelerating STAT3 dephosphorylation. This novel negative regulator reduces phosphorylated STAT3 levels and hinders tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Constitutive STAT3 activation drives tumorigenesis in various cancers, including melanoma.
  • Mechanisms for negative regulation of STAT3 phosphorylation remain incompletely understood.

Purpose of the Study:

  • To identify novel negative regulators of STAT3 phosphorylation.
  • To elucidate the role of SIPAR in melanoma progression.

Main Methods:

  • Investigated the interaction between SIPAR and STAT3 using co-immunoprecipitation assays.
  • Assessed the impact of SIPAR overexpression and depletion on STAT3 phosphorylation levels.
  • Evaluated the effect of SIPAR on melanoma cell growth and STAT3 target gene expression.

Main Results:

  • SIPAR directly interacts with STAT3 following IL-6 stimulation.
  • SIPAR overexpression decreases, while SIPAR depletion enhances, STAT3 phosphorylation.
  • SIPAR inhibits melanoma cell proliferation by reducing phosphorylated STAT3 and its downstream target gene expression.

Conclusions:

  • SIPAR acts as a novel negative regulator of STAT3 activity.
  • SIPAR represses melanoma progression by promoting STAT3 dephosphorylation.
Keywords:
DephosphorylationMelanomaSIPARSTAT3

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.